Related Experiment Video
Updated: Sep 11, 2025

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
Published on: January 10, 2013
The Analgesic and Antispastic Effects of Epidural Spinal Stimulation Depending on the Frequency and Intensity After
Jinseung Lee1, Wonok Kang2, Wonsuk Choi3
1Rehabilitation Science Program, Department of Health Science, Graduate School, Korea University, Seoul, Republic of Korea; Transdisciplinary Major in Learning Health Systems, Department of Healthcare Sciences, Graduate School, Korea University, Seoul, Republic of Korea.
Objectives:
Neuropathic pain and spasticity after spinal cord injury (SCI) are intractable conditions that represent distinct outcomes of sensory and motor dysfunction. Spinal cord stimulation (SCS) has been proposed as a potential therapy for these conditions. However, the therapeutic effects of different SCS parameters and their underlying mechanisms remain unclear. The present study aimed to investigate the therapeutic effects of a developed epidural SCS system on SCI-induced pain and spasticity, and to explore its underlying mechanisms in modulating microglia activation.
Materials And Methods:
Male Sprague-Dawley rats underwent contusive SCI at T10 segment using an Infinite Horizons impactor, and an epidural SCS system was implanted two weeks after SCI. Mechanical sensitivity and spasticity were assessed using paw withdrawal threshold and modified Ashworth scale. Epidural SCS was applied at low frequency (LF; 50 Hz) or high frequency (HF; 1 kHz) with intensities of 40% or 80% of the motor threshold (MT). Sham control rats underwent SCS implantation without electrical stimulation. Immunohistochemistry was performed to evaluate microglia activation in the lumbar spinal segments.
Results:
HF with 80% MT intensity showed a higher effect on neuropathic pain and spasticity, whereas LF with 40% MT intensity showed a lower effect. Although SCS did not alter the number of microglia in the lumbar spinal segments, both LF and HF with 80% MT intensity significantly decreased the proportion of activated microglia in both dorsal and ventral horns compared with the sham group.
Conclusion:
These findings show that the epidural SCS with 80% MT effectively alleviates neuropathic pain and spasticity by reducing spinal microglial activation. These results highlight the importance of optimizing stimulation parameters to achieve therapeutic benefits in clinical settings.
More Related Videos
04:42Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
Published on: June 26, 2018
06:55Author Spotlight: Advancing Spinal Cord Stimulation - Exploring the Cellular Responses of Motor Neurons Through Patch-Clamp Electrophysiology
Published on: September 8, 2023
Related Concept Videos
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Local Anesthetics: Clinical Application as Spinal Anesthesia
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Skeletal Muscle Relaxants: Therapeutic Uses